Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 418

1.

Surface loop dynamics in adeno-associated virus capsid assembly.

DiPrimio N, Asokan A, Govindasamy L, Agbandje-McKenna M, Samulski RJ.

J Virol. 2008 Jun;82(11):5178-89. doi: 10.1128/JVI.02721-07. Epub 2008 Mar 26.

2.

Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus.

Warrington KH Jr, Gorbatyuk OS, Harrison JK, Opie SR, Zolotukhin S, Muzyczka N.

J Virol. 2004 Jun;78(12):6595-609.

3.

Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism.

Wu P, Xiao W, Conlon T, Hughes J, Agbandje-McKenna M, Ferkol T, Flotte T, Muzyczka N.

J Virol. 2000 Sep;74(18):8635-47.

4.
5.

Comparative analysis of adeno-associated virus capsid stability and dynamics.

Rayaprolu V, Kruse S, Kant R, Venkatakrishnan B, Movahed N, Brooke D, Lins B, Bennett A, Potter T, McKenna R, Agbandje-McKenna M, Bothner B.

J Virol. 2013 Dec;87(24):13150-60. doi: 10.1128/JVI.01415-13. Epub 2013 Sep 25.

6.

Limitations of encapsidation of recombinant self-complementary adeno-associated viral genomes in different serotype capsids and their quantitation.

Wang Y, Ling C, Song L, Wang L, Aslanidi GV, Tan M, Ling C, Srivastava A.

Hum Gene Ther Methods. 2012 Aug;23(4):225-33. doi: 10.1089/hgtb.2012.090.

7.

The assembly-activating protein promotes capsid assembly of different adeno-associated virus serotypes.

Sonntag F, Köther K, Schmidt K, Weghofer M, Raupp C, Nieto K, Kuck A, Gerlach B, Böttcher B, Müller OJ, Lux K, Hörer M, Kleinschmidt JA.

J Virol. 2011 Dec;85(23):12686-97. doi: 10.1128/JVI.05359-11. Epub 2011 Sep 14.

8.

Proteolytic mapping of the adeno-associated virus capsid.

Van Vliet K, Blouin V, Agbandje-McKenna M, Snyder RO.

Mol Ther. 2006 Dec;14(6):809-21. Epub 2006 Sep 27.

9.

Adeno-associated Virus (AAV) Assembly-Activating Protein Is Not an Essential Requirement for Capsid Assembly of AAV Serotypes 4, 5, and 11.

Earley LF, Powers JM, Adachi K, Baumgart JT, Meyer NL, Xie Q, Chapman MS, Nakai H.

J Virol. 2017 Jan 18;91(3). pii: e01980-16. doi: 10.1128/JVI.01980-16. Print 2017 Feb 1.

10.
11.

Structural insights into adeno-associated virus serotype 5.

Govindasamy L, DiMattia MA, Gurda BL, Halder S, McKenna R, Chiorini JA, Muzyczka N, Zolotukhin S, Agbandje-McKenna M.

J Virol. 2013 Oct;87(20):11187-99. doi: 10.1128/JVI.00867-13. Epub 2013 Aug 7.

12.

Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding.

Opie SR, Warrington KH Jr, Agbandje-McKenna M, Zolotukhin S, Muzyczka N.

J Virol. 2003 Jun;77(12):6995-7006.

13.
14.

Intra- and inter-subunit disulfide bond formation is nonessential in adeno-associated viral capsids.

Pulicherla N, Kota P, Dokholyan NV, Asokan A.

PLoS One. 2012;7(2):e32163. doi: 10.1371/journal.pone.0032163. Epub 2012 Feb 28.

15.

Nuclear translocation of adeno-associated virus type 2 capsid proteins for virion assembly.

Popa-Wagner R, Sonntag F, Schmidt K, King J, Kleinschmidt JA.

J Gen Virol. 2012 Sep;93(Pt 9):1887-98. doi: 10.1099/vir.0.043232-0. Epub 2012 Jun 13.

PMID:
22694902
16.

Mutagenesis of adeno-associated virus type 2 capsid protein VP1 uncovers new roles for basic amino acids in trafficking and cell-specific transduction.

Johnson JS, Li C, DiPrimio N, Weinberg MS, McCown TJ, Samulski RJ.

J Virol. 2010 Sep;84(17):8888-902. doi: 10.1128/JVI.00687-10. Epub 2010 Jun 23.

17.

Cryo-electron Microscopy Reconstruction and Stability Studies of the Wild Type and the R432A Variant of Adeno-associated Virus Type 2 Reveal that Capsid Structural Stability Is a Major Factor in Genome Packaging.

Drouin LM, Lins B, Janssen M, Bennett A, Chipman P, McKenna R, Chen W, Muzyczka N, Cardone G, Baker TS, Agbandje-McKenna M.

J Virol. 2016 Sep 12;90(19):8542-51. doi: 10.1128/JVI.00575-16. Print 2016 Oct 1.

18.

Structure and dynamics of adeno-associated virus serotype 1 VP1-unique N-terminal domain and its role in capsid trafficking.

Venkatakrishnan B, Yarbrough J, Domsic J, Bennett A, Bothner B, Kozyreva OG, Samulski RJ, Muzyczka N, McKenna R, Agbandje-McKenna M.

J Virol. 2013 May;87(9):4974-84. doi: 10.1128/JVI.02524-12. Epub 2013 Feb 20.

19.

Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups.

Rabinowitz JE, Bowles DE, Faust SM, Ledford JG, Cunningham SE, Samulski RJ.

J Virol. 2004 May;78(9):4421-32.

20.

Impact of VP1-specific protein sequence motifs on adeno-associated virus type 2 intracellular trafficking and nuclear entry.

Popa-Wagner R, Porwal M, Kann M, Reuss M, Weimer M, Florin L, Kleinschmidt JA.

J Virol. 2012 Sep;86(17):9163-74. doi: 10.1128/JVI.00282-12. Epub 2012 Jun 13.

Supplemental Content

Support Center